CME Group stock price forecast: consolidation likely as CME tests near-term support after 1.21% drop

CME Group stock price forecast: consolidation likely as CME tests near-term support after 1.21% drop
CME Group slides 1.21% today

CME Group will bring Avalanche futures to its crypto suite on May 4, pending regulatory review.

Highlights

  • CME Group faces persistent downside pressure, trading below key short- and medium-term moving averages but still above long-term support.
  • Momentum indicators remain bearish and weak, with the stock approaching oversold territory and volatility elevated at 6.34%.
  • Baseline scenario anticipates consolidation between $291.00 and $299.00, with a bullish breakout likely only if resistance at $303.56–$306.74 is breached.

The company said the expansion continues. Details remain subject to regulatory approval.

Seller pressure prevails as price tests key support and resistance

CME Group is trading at $295.30, which is below the MA-20 ($303.56) and MA-50 ($305.78), but above the MA-200 ($280.69), signaling short- and medium-term pressure from sellers while the longer-term trend still finds support above key averages. The Ichimoku Kijun on D1 stands at $306.74, acting as immediate resistance for the current price; near-term support is seen at the MA-100 ($290.27) and MA-200 ($280.69), while resistances are marked at MA-20 ($303.56) and the Kijun/MA-50 cluster ($305.78–$306.74).

Momentum weakens as downside persists and stock approaches oversold zone

Momentum signals on D1 are bearish, with MACD firmly in sell territory and ADX indicating a weak, non-directional trend. RSI and CCI are both at low-to-neutral levels, and Stoch RSI sits below 30, suggesting the price is approaching oversold conditions even as BBP reflects clear seller dominance intraday. The Awesome Oscillator is neutral, offering little confirmation for the prevailing trend. CME has fallen $9.81 (3.22%) over the past week, declining from $305.11 and now trades at the very bottom of its weekly range, where volatility stands at 6.34%. In today's session, the stock has lost 1.21%, underscoring persistent downside pressure and marking a steady decline from the week’s high.

Upside favored given bullish signals, with volatility sustaining risk of reversal

For the coming week, the expected range is $291.00 to $299.00, reflecting elevated near-term volatility but keeping the price well above the 52-week low ($251.90) and below the recent yearly high ($329.16). Based on W1 signals (with three of four—MA-50, RSI, ADX, MACD—showing Buy/Strong Buy), the probability of a price increase is more than 80%, with a price drop being less likely. In the baseline scenario, CME consolidates near current levels. A bullish breakout would require a close above immediate resistance at $303.56–$306.74, while a bearish scenario may unfold if price slips below $290.27, bringing last line support at $280.69 into focus.

Previously it was reported that CME Group was experiencing persistent short-term bearish momentum, with technical signals suggesting potential stabilization between key support and resistance levels. Building on that analysis, readers should now monitor for any decisive breakout or reversal as a shift beyond established boundaries may present actionable trading opportunities.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.